ALKYLAMINE — Alkyl Amines Chemicals Balance Sheet
0.000.00%
- IN₹83.74bn
- IN₹81.72bn
- IN₹15.72bn
- 98
- 11
- 35
- 45
Annual balance sheet for Alkyl Amines Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,552 | 615 | 172 | 304 | 2,028 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,463 | 3,054 | 2,886 | 2,308 | 2,519 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,279 | 5,376 | 5,006 | 4,434 | 6,301 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,945 | 7,698 | 10,676 | 11,211 | 10,933 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 11,453 | 13,713 | 15,919 | 15,836 | 17,889 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,818 | 3,279 | 3,542 | 2,279 | 2,452 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,529 | 3,815 | 4,230 | 3,165 | 3,864 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 7,925 | 9,898 | 11,689 | 12,671 | 14,025 |
| Total Liabilities & Shareholders' Equity | 11,453 | 13,713 | 15,919 | 15,836 | 17,889 |
| Total Common Shares Outstanding |